Parthenolide derivatives reduce PKM2 expression in CRC cells, inhibit the PKM2/STAT3 signaling pathway, and PKM2 dimerization in nuclear translocation, inhibiting CRC tumor growth (149). This evidence concerns the gene PKM and neoplasm.